Gene Overdosage and comorbidities during the early lifetime in Down Syndrome

Explore

News & Events

More news
19 September 2024

10th Steering Committee (SC) Meeting

The 10th GO-DS21 Steering Committee (SC) meeting takes place remotely on the 19th of September 2024 with the objective to prepare the upcoming project review meeting by the European Commission.

News & Events

More news
19 September 2024

10th Steering Committee (SC) Meeting

The 10th GO-DS21 Steering Committee (SC) meeting takes place remotely on the 19th of September 2024 with the objective to prepare the upcoming project review meeting by the European Commission.

Summary Statement

Clinicians, pathophysiologists, integrative bioinformaticians and artificial intelligence computer scientists working to unravel intrinsic and extrinsic mechanisms that impact on Down Syndrome (DS) comorbidity (focusing on obesity and intellectual disability. The examination of the pathways and mechanisms involved in comorbidities and multi-morbidities that induce the coexistence of two or more diseases in an individual is of major importance for the effective treatment of patients suffering from DS, obesity and mental disorders.

To achieve a system view to this disease we will integrate multiple datasets using new multi-layered approaches, which offer a unique opportunity for the integration and synthesis of molecular (multi-OMICS) preclinical (cellular and animal) and clinical datasets and metadata (environment, patient history) to understand the mechanisms of comorbidities.

In GO-DS21 we plan to use publicly available and self-developed bioinformatics tools, network science, statistical machine learning software and mathematical modeling approaches to unravel the shared etiological mechanisms in DS and the associated comorbidities, mainly obesity and intellectual disability.

Learn More

Our vision

Learn more

Why it matters

Learn more
X (Twitter)
YouTube
LinkedIn